Ranbaxy, GSK will test new respiratory compound
As part of their recently signed agreement, Ranbaxy will be able to progress and further profile this drug candidate through preclinical studies needed to support an investigational new
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.